chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Mild sore throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Mild sore throat). At the time of the report, OROPHARYNGEAL PAIN (Mild sore throat) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jul-2021, SARS-CoV-2 test: positive (Positive) tested positive for Covid (variant unknown) on 07/28.         No concomitant medications were reported.  No treatment medications were reported.
Severe systemic inflammatory symptoms including high fever, shaking chills, full body myalgias, diffuse arthralgias (especially neck and back), headache, full body dermatologic allodynia - all beginning approximately 8-10hrs after vaccine administration and lasting up to 24hrs afterwards with only mild amelioration by NSAIDs. Severe arm soreness/pain including limited ability to ABduct the arm for 3 days due to pain.
pt c/o abd pain, nausea & leg pain approx 2hr p/vax given while eating a hamburger @ burger king;
This case was reported by a other health professional and described the occurrence of hives in a 52-year-old female patient who received Influenza vaccine (batch number 3E532, expiry date June 2015). On 28th October 2014, the patient received Influenza vaccine. On 28th October 2014, an unknown time after receiving Influenza vaccine, the patient experienced hives, erythema and swelling. On 2nd November 2014, the outcome of the hives, erythema and swelling were recovered/resolved. The reporter considered the hives, erythema and swelling to be probably related to Influenza vaccine. Additional information: Injection given at agency by physician (company hired to administer flu vaccine); hive, redness, swelling on her extremities and trunk. This is the 1st time she ever received.
PATIENT CAME IN FOR HEALTH SCREEN FOR NURSING SCHOOL 12/17/07. ALL SCREENING TESTS AND HEPATITIS SCREENS WERE NEGATIVE. JANUARY 10, PATIENT BEGAN COMPLAINING OF ABD PAIN. ULTRASOUND ORDERED AND LFT'S ORDERED BOTH WERE NEGATIVE. PATIENT CONTINUED WITH SYMPTOMS WHICH PROGRESSED INTO WEIGHT LOSS, FATIGUE, MALAISE, BODY RASH,BROWN URINE, GREY STOOL AND FINALLY JAUNDICE. PATIENT WAS FINALLY DX WITH ACUTE HEPATITIS C ON MARCH 5, 2008. PATIENT WAS UNDER STRESS BECAUSE HER MOTHER WAS SERIOUSLY ILL ALL THROUGH FEBRUARY SO SHE THOUGHT IT WAS STRESS RELATED.   ULTRASOUNDS WERE DONE IN EACH MONTH WHICH WERE NEGATIVE. AT THE END OF FEBRUARY PATIENT DEVELOPED A BLISTERY RASH ON HER UPPER BODY AT THE TIME LABS WERE OBTAINED AGAIN WHICH REVEALED ELEVATED LIVER FUNCTION STUDIES IN MARCH 2008
injection given and patient almost immediately began feeling unwell, patient asked for some water and sat with mom. Patient then stated she was going to throw up and vomited.
tiny bit of fever of 2 seconds; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (tiny bit of fever of 2 seconds) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Fatty liver.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (tiny bit of fever of 2 seconds). At the time of the report, PYREXIA (tiny bit of fever of 2 seconds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported.   No treatment was reported.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with GARDASIL, intramuscular injection, "1 single shot". Dose, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The physician reported that "on an unspecified date the anonymous patient (demographics unknown) was hospitalized and diagnosed with having pancreatitis while using GARDASIL". The outcome of pancreatitis while using GARDASIL was unknown. Upon internal review the event pancreatitis was considered as an other important medical event. Additional information has been requested.
Chills, muscle aches, nausea, pain, redness and swelling around area of vaccination. With the exception of the pain, redness and swelling symptoms lasted for approximately 24 hours.
This was from the Booster shot, my third shot from Moderna.  At time of shot, no reaction but that night I had fever and chills and for that day and another I was in bed not feeling well.  Then felt better but starting itching the top of my head and foot.  About 9-11 days later I started to notice red spots and raised spots that came and went all over my body.  Through google search of pictures etc. I think these are called hives or rash.  A spot will appear then disappear after 10-30 minutes.  I have no other symptoms of anything, I feel fine, no fever and other than this I am fine.  I haven't changed my diet or soap or laundry detergent.  The only thing that changed is I got the booster shot.  Nothing else has occurred in my life.  I don't have a pet and no living situation is unchanged and I don't have stress-other than wondering what this is and if I should worry about it.   I don't know why this isn't being more widely told to the public.
No additional AE; temperature excursion in which PROQUAD and V ARlV AX may have been administered to patient(s).; This spontaneous report as received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 27-APR-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # T025507, expiration date: 23-JAN-2022, dose 1 (formulation, strength, exact dose, frequency, route of administration were not reported) for prophylaxis. On an unknown date, the dose of the vaccine was exposed to temperature excursion at 17.32 Fahrenheit degrees (F) for 1 hour 22 minutes. There was no previous temperature excursion reported. The call was due to digital data logger. No additional adverse event was reported.
4 days after uneventful vaccine administration, client's left arm became painful from shoulder to hand, radiating to pectoral muscles and into axillary area.
Mother reports redness & swelling at injection site on left upper thigh. Area hard & tender to touch. Child extremely fussy, fatigue & no appetite.
can barely walk; This case was reported by a consumer via interactive digital media and described the occurrence of walking difficulty in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2022, the patient received Shingrix. In February 2022, less than 3 weeks after receiving Shingrix, the patient experienced walking difficulty. On an unknown date, the outcome of the walking difficulty was not recovered/not resolved.   It was unknown if the reporter considered the walking difficulty to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient stated that he or she could barely walk from taking the vaccine back in February now what he or she could do to walk right again.
This spontaneous report as received from a healthcare worker refers to multiple male infants between the ages of 2 and 4 months. It was reported that the patients had no medical history and no drug reactions or allergies. On an unknown date the patients were vaccinated with ROTATEQ, 2 ml, oral. It was reported that the patients were not on any medications concomitantly. On an unknown date the patients had difficulty swallowing (dysphagia) during administration. It was reported that the patients sought medical attention and also reported that the event occurred in office. It was reported that no treatment was given for the events. There was no lab diagnostics studies performed. It was also reported that the did not experience any further difficulty with swallowing after administration. The action taken with the therapy with ROTATEQ was unknown. The outcome of dysphagia was unknown. The relatedness of the events to the therapy with ROTATEQ was unknown. There was no product quality complaint reported. This is one of the two reports from the same source. Additional information has been requested.
Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/15/2023 Discharge Date: Apr 20, 2023  PRESENTING PROBLEM: Shortness of breath [R06.02]   HOSPITAL COURSE: 86-year-old gentleman admitted with evidence of recurrent diastolic heart failure on 4/15.  Patient has a past history of possible hypertrophic cardiomyopathy. He was incidentally positive for COVID19 on admission.  On previous echocardiogram is also noted to have moderate aortic stenosis with a concern that the evaluation done in March of 2023 may be underestimating the severity of AS.  Previous outpatient evaluation has shown abnormal light chains raising concern for possible cardiac amyloidosis.  The patient was treated with IV diuresis with gradual improvement.  Cardiology was consulted and recommended increasing the Lasix dosing in addition to proceeding with a PYP scan which was completed and demonstrated evidence of cardiac amyloidosis.  They felt that the patient could have a outpatient TEE to investigate the severity of his AS due to current COVID19 infection. Patient significantly improved on day of discharge, swelling significantly reduced. Kidney function remained stable around baseline. He will DC on BID lasix for 4 more days then transition to daily lasix. He denied any new complaints on day of discharge, spouse updated on plan at bedside.
Just a little bit of tiredness but minor; Dizzy spells; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spells) and FATIGUE (Just a little bit of tiredness but minor) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced DIZZINESS (Dizzy spells). On an unknown date, the patient experienced FATIGUE (Just a little bit of tiredness but minor). At the time of the report, DIZZINESS (Dizzy spells) and FATIGUE (Just a little bit of tiredness but minor) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided.
Fever/a lot of fever/fever was 101; Tiredness/Felt tired; Severe flu symptoms; sweatiness/felt kind of like sweaty/he started to sweat and everything; Was cold when he went to bed; Was kind of low for a while; had a little bit dizziness; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Severe flu symptoms), HYPERHIDROSIS (sweatiness/felt kind of like sweaty/he started to sweat and everything), FEELING COLD (Was cold when he went to bed), VACCINATION COMPLICATION (Was kind of low for a while) and DIZZINESS (had a little bit dizziness) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 010M20A and 012LA0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunocompromised.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced INFLUENZA (Severe flu symptoms), HYPERHIDROSIS (sweatiness/felt kind of like sweaty/he started to sweat and everything), FEELING COLD (Was cold when he went to bed), VACCINATION COMPLICATION (Was kind of low for a while), DIZZINESS (had a little bit dizziness), CHILLS (Chills) and FATIGUE (Tiredness/Felt tired). On an unknown date, the patient experienced PYREXIA (Fever/a lot of fever/fever was 101). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA (Severe flu symptoms), HYPERHIDROSIS (sweatiness/felt kind of like sweaty/he started to sweat and everything), FEELING COLD (Was cold when he went to bed), VACCINATION COMPLICATION (Was kind of low for a while), DIZZINESS (had a little bit dizziness), CHILLS (Chills), PYREXIA (Fever/a lot of fever/fever was 101) and FATIGUE (Tiredness/Felt tired) outcome was unknown.            No Concomitant product use was reported. No treatment information was provided.  The patient received a third Moderna shot on 12-Oct-2021 and believed that they got a regular Moderna shot as they experienced the same side effects post the first dose as well. The patient had severe flu symptoms, had fever, developed chills, a lot of fever, sweatiness, and tiredness.  At the vaccination place, they considered that dose was the booster and that patient was immunocompromised as the patient was over 65 years.   This case was linked to MOD-2021-353320, MOD-2021-353221 (Patient Link).
Child "staring into space", wouldn't respond when name called, drooling , & szing followed by deep unarousable sleep. Temp 105 in ER.
Joint aches (hips); tiredness; fever 102; patient is taking anastrazole for breast cancer; patient is taking anastrazole for breast cancer; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient, who was also 53-year-old at the time of vaccination, received first dose of bnt162b2 (BNT162B2), lot number: EL3247, via an unspecified route of administration on left leg on 29Jan2021 14:45 as SINGLE DOSE for COVID-19 immunization. Medical history included breast cancer, stroke, migraines is situ melanoma, penicillin allergy, and COVID-19 prior vaccination. Concomitant medication included atorvastatin (LIPITOR), acetylsalicylic acid (BABY ASPIRIN), anastrozole, and colecalciferol (VITAMIN D). On 30Jan2021 04:30, the patient experienced Joint aches (hips), tiredness, and fever 102 (unknown unit). The outcome of the events was recovering. No treatment given for the events. The patient has COVID-19 prior vaccination. The patient was not tested for COVID-19 post vaccination.
High fevers starting 7 days after and lasting 6 days. Cold and flu symptoms lasting 6 days.
NASAL CONGESTION, DRY COUGH, FATIGUE, FEVER, CHILLS
lips, mouth and tongue were numb; This is a spontaneous report from a contactable nurse (patient) via a Pfizer sponsored program. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunization. Medical history included diagnosed with COVID on 03Nov2020. Ever since the patient had had COVID. The patient had a terrible burning sensation in mouth and tongue.  The patient's concomitant medications were not reported. Immediately after the vaccine, the pateint's lips, mouth and tongue were numb and felt full, lasted for approx 2 hours. Later that evening the burning the patient had since recovering from covid had stopped. The outcome of the event was unknown.   Information on the lot/batch number had been requested.
15 minutes after vaccine, he began to cough, eyes were swollen.  Mother left clinic and went to ED. On the way to the emergency department complained of abdominal pain. No wheezing, no vomiting.
Vaccine given on 10/19/12, no obvious reaction in 20 min. pt left. Went to ER on 11/9/12 complaining of numbness & pain in LA where vaccine was given. Patient was given NORCO 5/325, ROBAXIN 750mg & LIDODERM patches. Pt. had no breathing problem.
Hives began a few hours after shot  *but had hives off and on earlier in week.
pain in both shoulders and neck area; pain in both shoulders and neck area/ constantly sore in my neck; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in left arm on 17Feb2021 13:00 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunization. The patient's medical history was not reported; no known allergies. Concomitant medication included hydrochlorothiazide taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient did not have COVID and did not receive any other vaccine in four weeks. On an unspecified date, the patient was having pain in both shoulders and neck area for last two to three weeks. His shoulders ached down to the sockets and constantly sore in his neck. No treatment was received for the events. Post-vaccination, the patient has not been tested for COVID. Outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Adverse Event: Distal half of the right thigh pink, warm, and edematous; pink surrounds entire circumference of thigh. This was noticed by parent 24 hours after the injection. Treatment: Ibuprofen and Benadryl Q 6-8 hours. Cold compresses and elevation. Mom will monitor for worsening.  Outcome: TBD
Pt has a 51/2 51/2 cm swollen, red, warm area to left deltoid where the TRUMEMBA was given on 10/11/16.
symptoms were mild; fatigue; fever 103°F; weakness; chills; muscle ache; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (symptoms were mild), FATIGUE (fatigue), PYREXIA (fever 103°F), ASTHENIA (weakness) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (symptoms were mild), FATIGUE (fatigue), PYREXIA (fever 103°F), ASTHENIA (weakness), CHILLS (chills), MYALGIA (muscle ache) and DIZZINESS (dizziness). At the time of the report, ILLNESS (symptoms were mild) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-075629 (E2B Linked Report).; Sender's Comments:  MOD21-075629:
One day post vaccination the pt's arm was sore, red, and arm to touch from the upper arm to the elbow. Edema was also noted. Unspecified medical attention was sought, however it was noted that the pt was not seen in the ER or by a physician. follow up information from an physicians assistant reported that the pt's experiences have resolved. No further information is available.
This is a spontaneous report received from a non-contactable consumer (patient). This 25-year-old female patient receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on 08Apr2021 at 03:00 PM (lot unknown) as single dose at Right arm for COVID-19 immunization. The patient did not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Medical history and concomitant medications were not reported. The patient experienced Nausea, vomiting, fever, chills, headache on 02Apr2021. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was Not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse concerning an 11 or 12 year old daughter of a co-worker who was vaccinated with the first dose of GARDASIL.  The patient, was diagnosed of "viral meningitis" after receiving the first dose and was hospitalized for a few days.  The nurse reported that the patient was home as of 10-JUL-2008, but she still had left over symptoms.  The patient had not recovered.  No further information is available.
Injection site arm got tender; Injection site arm felt achy in forearm and shoulder; Injection site arm felt swollen in shoulder and forearm; tingling on both sides of my face; minor swelling in my throat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Injection site arm felt achy in forearm and shoulder), PERIPHERAL SWELLING (Injection site arm felt swollen in shoulder and forearm), PARAESTHESIA (tingling on both sides of my face), SWELLING (minor swelling in my throat) and TENDERNESS (Injection site arm got tender) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History Reported.     On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (Injection site arm felt achy in forearm and shoulder), PERIPHERAL SWELLING (Injection site arm felt swollen in shoulder and forearm), PARAESTHESIA (tingling on both sides of my face) and SWELLING (minor swelling in my throat). On 14-Apr-2021, the patient experienced TENDERNESS (Injection site arm got tender). On 13-Apr-2021, PARAESTHESIA (tingling on both sides of my face) and SWELLING (minor swelling in my throat) had resolved. At the time of the report, PAIN IN EXTREMITY (Injection site arm felt achy in forearm and shoulder), PERIPHERAL SWELLING (Injection site arm felt swollen in shoulder and forearm) and TENDERNESS (Injection site arm got tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Within 5 minutes post vax, the pt stated that she felt funny, her tongue felt thick and she experienced numbness in her toes. The pt was administered epinephrine and Benadryl parenterally and taken by ambulance to the hospital.
Initially bruising at injection site on day 2 with seasonal flu shot. Discomfort from (L) shoulder through wrist that has increased. Difficulty raising arm above head without discomfort. Feels better by 2/5/10 bruising gone still sore @ site in arms only.